Our 12th paper is on the front page of OncoImmunology

This happens once in a lifetime of research; for a scientist, its like being on the front page of Times Magazine. The paper is called: GC protein-derived macrophage-activating factor decreases a-N-acetylgalactosaminidase levels in advanced cancer patients. Or to translate: GcMAF decreases nagalase in advanced cancer patients. It follows the excellent improvements in 20 cancer patientsRead More